First, the good news. During last month's Infectious Diseases Society of America meeting in Philadelphia, researchers from the University of Iowa reported promising findings on a new drug capable of fighting disease-causing bacteria that have become resistant to existing antibiotics.
The drug, a synthetic agent called linezolid, has demonstrated universal effectiveness against strains of staphylococci, enterococci, and streptococci organisms despite their patterns of resistance to other antibiotics. "One of the most exciting potential uses for this new agent is the management of resistant gram-positive infections," said Michael Pfaller, MD, professor of pathology and public health.
Voelker R. Globe-trotting Bacteria. JAMA. 1999;282(24):2291. doi:10.1001/jama.282.24.2291
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: